7 questions answered from cited research · Plain language
Semaglutide can improve physical quality of life in people with schizophrenia and prediabetes, likely by helping with weight loss and metabolic health.
Read the full answer →A large meta-analysis found that about 47% of people with bipolar disorder experience mood-incongruent psychosis, and psychotic symptoms are common, especially in bipolar I disorder.
Read the full answer →Yes, recent studies show people with schizophrenia tend to have a higher resting heart rate, which may contribute to their increased risk of sudden cardiac death.
Read the full answer →Yes, GLP-1 drugs significantly reduce weight and HbA1c in people with severe mental illness, with low dropout rates, but benefits may fade after stopping.
Read the full answer →Yes, switching from olanzapine to cariprazine may help you lose weight, based on a 12-week study showing modest weight reduction compared to aripiprazole.
Read the full answer →Yes, schizophrenia is linked to a higher resting heart rate and increased risk of heart rhythm problems, according to a large meta-analysis.
Read the full answer →Yes, Perseris (risperidone) is FDA-approved for once-monthly subcutaneous injection to treat schizophrenia in adults.
Read the full answer →